Metadon Abcur Ab (Methadone Hydrochloride)

Methadone acts on opioid receptors to address conditions within the opioid dependence and pain management pathways.

• Opioid dependence treatment: stabilizes patients, reduces withdrawal symptoms and cravings during maintenance therapy.
• Chronic pain: provides long‑acting analgesia for severe, persistent pain unresponsive to other opioids.
• Acute severe pain: may be used when alternative analgesics are insufficient, offering potent opioid relief.

• Methadone is a high‑affinity agonist at the mu‑opioid receptor, producing analgesia and suppressing opioid withdrawal. It also antagonizes NMDA receptors, which may contribute to its efficacy in neuropathic pain and reduction of opioid tolerance. The combined actions modulate pain pathways and reward circuits in the central nervous system.

Methadone may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: increased sedation, especially at higher doses.
• Sweating: excessive perspiration without exertion.
• Dry mouth: reduced salivation causing discomfort.
• Weight gain: increased appetite and fluid retention.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be fatal.
• QT interval prolongation: cardiac rhythm disturbance increasing arrhythmia risk.
• Seizures: rare convulsive episodes, particularly with high plasma levels.
• Severe hypotension: sudden drop in blood pressure leading to dizziness or fainting.

Methadone requires careful monitoring due to its potency and pharmacologic profile.

• Assess organ function: evaluate hepatic and renal status before initiation.
• Monitor respiration: watch for signs of respiratory depression, especially during dose changes.
• Avoid in severe respiratory disease: patients with COPD or sleep apnea are at higher risk.
• Use caution with cardiac disorders: patients with known QT prolongation need ECG monitoring.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone interacts with several drug classes, necessitating vigilance.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, barbiturates): risk of profound sedation and respiratory depression.
• Monoamine oxidase inhibitors (MAOIs): can precipitate severe hypertension or serotonin syndrome.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase methadone plasma concentrations.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce methadone effectiveness.
• QT‑prolonging agents (e.g., macrolide antibiotics, fluoroquinolones): heighten risk of cardiac arrhythmias.
• Serotonergic drugs (e.g., SSRIs, tramadol): potential for serotonin syndrome, requiring symptom monitoring.